Results 351 to 360 of about 2,435,179 (382)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul H Parikh
exaly  

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

Nature, 1983
J. Arrang, M. Garbarg, J. Schwartz
semanticscholar   +1 more source

Cost-Effectiveness of Histamine Receptor-2 Antagonist Versus Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients*

Critical Care Medicine, 2014
R. MacLaren, Jon Campbell
semanticscholar   +1 more source

Analysis of Histamine Receptor Knockout Mice in Models of Inflammation

Journal of Pharmacology and Experimental Therapeutics, 2014
D. Neumann, E. Schneider, R. Seifert
semanticscholar   +1 more source

Role of the Histamine H3 Receptor in the Central Nervous System.

Handbook of Experimental Pharmacology, 2016
E. Schlicker, M. Kathmann
semanticscholar   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Histamine H3 receptor in primary mouse microglia inhibits chemotaxis, phagocytosis, and cytokine secretion

Glia, 2015
Tomomitsu Iida, T. Yoshikawa, T. Matsuzawa, Fumito Naganuma, Tadaho Nakamura, Yamato Miura, Attayeb Mohsen, R. Harada, R. Iwata, K. Yanai   +9 more
semanticscholar   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly